Results 191 to 200 of about 5,665,859 (214)
Some of the next articles are maybe not open access.
Annals of the Rheumatic Diseases, 2015
Background Anti-citrullinated protein antibody (ACPA) immune response occurs several years prior to the diagnosis of rheumatoid arthritis (RA). However, limited data are available on ACPA status in the general population compared to those who develop RA or inflammatory polyarthritis (IP) in the future. Objectives The aim of this study was to examine
S.M. Verstappen +9 more
openaire +1 more source
Background Anti-citrullinated protein antibody (ACPA) immune response occurs several years prior to the diagnosis of rheumatoid arthritis (RA). However, limited data are available on ACPA status in the general population compared to those who develop RA or inflammatory polyarthritis (IP) in the future. Objectives The aim of this study was to examine
S.M. Verstappen +9 more
openaire +1 more source
Annals of the Rheumatic Diseases, 2012
Background The complex processes of citrullination presents an ubiquitous pathophysiological procedure during inflammation. However, anti-citrullinated protein antibodies (ACPA) are highly specific for the rheumatoid arthritis (RA). In order to a variety of several autoimmune phenomenons during the course of lymphoma diseases the occurrence of ...
G. Assmann +5 more
openaire +1 more source
Background The complex processes of citrullination presents an ubiquitous pathophysiological procedure during inflammation. However, anti-citrullinated protein antibodies (ACPA) are highly specific for the rheumatoid arthritis (RA). In order to a variety of several autoimmune phenomenons during the course of lymphoma diseases the occurrence of ...
G. Assmann +5 more
openaire +1 more source
Rheumatology International, 2011
Autoantibodies in early rheumatoid arthritis (RA) have important diagnostic value. The association between the presence of autoantibodies against cyclic citrullinated peptide and the response to treatment is controversial. To prospectively evaluate a cohort of patients with early rheumatoid arthritis (
Licia Maria Henrique, da Mota +6 more
openaire +2 more sources
Autoantibodies in early rheumatoid arthritis (RA) have important diagnostic value. The association between the presence of autoantibodies against cyclic citrullinated peptide and the response to treatment is controversial. To prospectively evaluate a cohort of patients with early rheumatoid arthritis (
Licia Maria Henrique, da Mota +6 more
openaire +2 more sources
The Journal of the Association of Physicians of India, 2019
To evaluate the prevalence of anti- citrullinated protein antibodies (ACPA) in patients with a variety of rheumatic diseases other than rheumatoid arthritis (RA).144 cases of rheumatic diseases other than rheumatoid arthritis (RA) over a period of 1 year were recruited after consenting and followed up for 2 years.
Renu, Saigal +3 more
openaire +1 more source
To evaluate the prevalence of anti- citrullinated protein antibodies (ACPA) in patients with a variety of rheumatic diseases other than rheumatoid arthritis (RA).144 cases of rheumatic diseases other than rheumatoid arthritis (RA) over a period of 1 year were recruited after consenting and followed up for 2 years.
Renu, Saigal +3 more
openaire +1 more source
Annals of the Rheumatic Diseases, 2014
Background Anti-citrullinated protein antibody (ACPA) is a serum biomarker that is as sensitive as, but more specific than the rheumatoid factor (RF) and detected earlier in RA [1,2]. Although ACPAs are part of the ACR RA classification criteria, ACPA testing is not routinely paid for/accessible in all jurisdictions. Objectives The impact of missing
J. Shu +8 more
openaire +1 more source
Background Anti-citrullinated protein antibody (ACPA) is a serum biomarker that is as sensitive as, but more specific than the rheumatoid factor (RF) and detected earlier in RA [1,2]. Although ACPAs are part of the ACR RA classification criteria, ACPA testing is not routinely paid for/accessible in all jurisdictions. Objectives The impact of missing
J. Shu +8 more
openaire +1 more source
Annals of the Rheumatic Diseases, 2015
Background Bone destruction in rheumatoid arthritis (RA) remains a main concern in the clinical practice where the destructed joints may lead to impaired normal functional activity of patients. Antibodies against citrullinated proteins (ACPA) and high levels of Receptor activator of nuclear factor kappa-B ligand (RANKL) have been linked to altered ...
A.F. Elbelasy +3 more
openaire +1 more source
Background Bone destruction in rheumatoid arthritis (RA) remains a main concern in the clinical practice where the destructed joints may lead to impaired normal functional activity of patients. Antibodies against citrullinated proteins (ACPA) and high levels of Receptor activator of nuclear factor kappa-B ligand (RANKL) have been linked to altered ...
A.F. Elbelasy +3 more
openaire +1 more source
Annals of the Rheumatic Diseases, 2012
Background Arthritis is known to associate with upregulation of inflammatory mediators in the central nervous system (CNS) as shown in earlier experimental studies (1). However, little is known about the possible presence of intrathecal immune activation in RA patients, which may have importance for cerebral symptoms, such as fatigue.
E. Le Maitre +5 more
openaire +1 more source
Background Arthritis is known to associate with upregulation of inflammatory mediators in the central nervous system (CNS) as shown in earlier experimental studies (1). However, little is known about the possible presence of intrathecal immune activation in RA patients, which may have importance for cerebral symptoms, such as fatigue.
E. Le Maitre +5 more
openaire +1 more source

